Market Forecast by Countries (United States, Canada), By Type (Standard pen needles, Safety pen needles), By Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin therapy, Glucagon-like Peptide-1 (GLP-1) therapy, Growth hormone therapy, Other therapies) And Competitive Landscape
Product Code: ETC4622065 | Publication Date: Jul 2023 | Updated Date: Mar 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 300 | |
Report Name | North America Pen Needles Market |
Forecast Period | 2025-2031 |
Market Size | USD 3.8 billion by 2031 |
CAGR | 10.2% |
Growing Sector | Healthcare |
North America Pen Needles Market report thoroughly covers the market By Countries, By type, by length, by therapy. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
North America Pen Needles Market was valued at USD 2.3 billion and is expected to reach USD 3.8 billion, growing at a CAGR of around 10.2% from 2025 to 2031. Pen needles are an important part of diabetes management, used for injecting insulin from a pen device into the body. They come in different sizes and gauges to fit varying injection needs. The North America pen needles market has been rapidly growing due to the increasing prevalence of diabetes in the region.
The North America pen needle market is expected to witness significant growth in the forecast period of 2025-2031. The market is driven by various factors such as increasing prevalence of diabetes, rising adoption of injectable drugs, technological advancements in pen needle design, and growing awareness about safety and convenience offered by pen needles over traditional syringes.
According to 6Wresearch, the North America Pen Needles Market Size is expected to reach a significant CAGR of 10.2% during the forecast period 2025-2031. A primary contributor is the increasing prevalence of diabetes in the region, coupled with the growing adoption of advanced insulin delivery devices, such as pen needles, by both healthcare professionals and patients. These devices offer greater convenience, ease of use, and precise dosing compared to traditional syringes. Additionally, technological innovations in pen needle design, including shorter, thinner needles and enhanced compatibility with various insulin pens, are expected to further stimulate market expansion. The rising elderly population, more susceptible to diabetes, also contributes to the demand for pen needles. Government initiatives and increased healthcare spending on chronic disease management will likely bolster market growth.
However, challenges such as high diabetes prevalence, competitive pressures, regulatory complexities, and limited awareness about the benefits of pen needles may impact the market. Strategic product innovation and partnerships with healthcare organizations will be key to overcoming these challenges and driving market advancement.
The North America Pen Needles Market is projected to experience substantial growth from 2025 to 2031. Key trends include the increasing adoption of Bluetooth-enabled smart pens for insulin delivery, driven by the demand for convenient and user-friendly devices for diabetes management. Additionally, there is a growing emphasis on eco-friendly materials, such as recycled plastic and biodegradable substances, reflecting heightened environmental awareness within the healthcare sector. Government initiatives supporting diabetes care and advancements in pen needle technology further contribute to the market’s growth.
The rising prevalence of diabetes and the shift towards self-administration of insulin will fuel demand in this region. Other emerging trends involve the development of pen needles with safety features, such as retractable needles, and collaborations between pharmaceutical companies and device manufacturers to create tailored solutions. These innovations highlight a focus on personalized healthcare, enhancing the patient experience and driving market expansion, presenting a promising investment opportunity for stakeholders.
The North America Pen Needles Market is poised for substantial growth in the coming years, presenting a valuable investment opportunity for businesses and investors seeking to capitalize on the rising demand for insulin pens and other injectable devices. A key driver of this growth is the increasing prevalence of diabetes, particularly in the United States, fuelled by aging populations and escalating obesity rates. This has created a demand for efficient and convenient insulin delivery methods, with pen needles emerging as a preferred solution among both patients and healthcare providers.
Technological advancements have further improved the precision and ease of use of pen needles, bolstering market expansion. Additionally, growing government initiatives and healthcare investments in diabetes management are expected to sustain the demand for these devices. As such, the North American market offers significant potential for companies looking to enter or expand within the medical device sector.
The North America Pen Needles Market is highly competitive and is dominated by some of the leading players in the industry. These players constantly strive to innovate and introduce new products, while also expanding their geographical presence through collaborations and partnerships. Some of the top companies operating in this market include: Becton Dickinson and Company, Novo Nordisk A/S, Ypsomed AG, Owen Mumford Ltd., Terumo Corporation, HTL-STREFA S.A., Sanofi S.A., UltiMed, Inc.
These companies are known for their technologically advanced products that cater to various types of pen injectors. They also focus on providing user-friendly and cost-effective solutions to meet the growing demand for pen needles in the North America region. With their strong market presence and continuous efforts towards product innovation, these companies are expected to maintain their leading positions in the North America pen needles market in the coming years.
The North America pen needles market is poised for significant growth between 2025 and 2031, primarily driven by the rising incidence of diabetes and the increasing use of injectable medications. Government regulations, however, play a pivotal role in influencing the market's dynamics. Regulatory bodies have established stringent guidelines for the manufacturing, labelling, and packaging of pen needles to ensure their safety and efficacy. Furthermore, there is a growing emphasis on promoting auto-injectors to enhance patient compliance and minimize needle stick injuries. As a result, these regulations will continue to shape the market's development in the years ahead. Overall, government regulations are critical in fostering a competitive and sustainable pen needles market in North America, and it will be essential for regulatory bodies to adapt their guidelines in response to emerging technologies and innovations.
The North America Pen Needles market holds significant potential for further innovation and growth. As digital health technologies evolve, there may be advancements in integrating smart features into pen needles, enhancing the tracking and management of insulin doses. Collaborative efforts between pharmaceutical companies and device manufacturers could lead to more personalized and targeted solutions for patients. With healthcare systems increasingly prioritizing chronic disease management, the market's future appears promising.
Areas for further development include improving needle design to reduce pain, exploring eco-friendly materials, and incorporating smart technology for precise dosing. Additionally, the rise of home-use pen needles may offer patients greater convenience and improve treatment adherence. As healthcare continues to emphasize patient-centered care, the North America Pen Needles market is set for sustained growth, playing a crucial role in diabetes management and enhancing the quality of life for millions.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
The United States is expected to lead in the North America Pen Needles market due to its high healthcare expenditure and favourable reimbursement policies for diabetes management products. Canada is also expected to witness significant growth in this market, driven by government initiatives to improve access to affordable insulin therapy for patients.
According to Ravi Bhandari, Research Head, 6Wresearch, the standard pen needles segment is anticipated to hold the largest market share due to their low cost and widespread usage in insulin therapy. The safety pen needles segment is also expected to see significant growth due to the increasing focus on preventing needle stick injuries and infections among healthcare professionals and patients.
The 4mm and 5mm segments are projected to dominate the market, as they are suitable for both paediatric and adult populations. However, the 6mm and 8mm segments are also expected to witness steady growth due to their versatility in various injection sites.
Insulin therapy is expected to lead the North America Pen Needles market, as insulin remains the primary treatment for diabetes. However, with the rise in prevalence of obesity and type 2 diabetes, glucagon-like peptide-1 (GLP-1) therapy is also expected to witness significant growth. Additionally, the growth hormone therapy segment is projected to see steady growth due to its increasing use in conditions such as growth hormone deficiency and Turner syndrome.
The market report has been segmented and sub-segmented into the following categories:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Pen Needles Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Pen Needles Market Revenues & Volume, 2021 & 2031F |
3.3 North America Pen Needles Market - Industry Life Cycle |
3.4 North America Pen Needles Market - Porter's Five Forces |
3.5 North America Pen Needles Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Pen Needles Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Pen Needles Market Revenues & Volume Share, By Length, 2021 & 2031F |
3.8 North America Pen Needles Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
4 North America Pen Needles Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Pen Needles Market Trends |
6 North America Pen Needles Market, 2021 - 2031 |
6.1 North America Pen Needles Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2 North America Pen Needles Market, Revenues & Volume, By Length, 2021 - 2031 |
6.3 North America Pen Needles Market, Revenues & Volume, By Therapy, 2021 - 2031 |
7 United States Pen Needles Market, 2021 - 2031 |
7.1 United States Pen Needles Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2 United States Pen Needles Market, Revenues & Volume, By Length, 2021 - 2031 |
7.3 United States Pen Needles Market, Revenues & Volume, By Therapy, 2021 - 2031 |
8 Canada Pen Needles Market, 2021 - 2031 |
8.1 Canada Pen Needles Market, Revenues & Volume, By Type, 2021 - 2031 |
8.2 Canada Pen Needles Market, Revenues & Volume, By Length, 2021 - 2031 |
8.3 Canada Pen Needles Market, Revenues & Volume, By Therapy, 2021 - 2031 |
9 North America Pen Needles Market Key Performance Indicators |
10 North America Pen Needles Market - Opportunity Assessment |
10.1 North America Pen Needles Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Pen Needles Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Pen Needles Market Opportunity Assessment, By Length, 2021 & 2031F |
10.4 North America Pen Needles Market Opportunity Assessment, By Therapy, 2021 & 2031F |
11 North America Pen Needles Market - Competitive Landscape |
11.1 North America Pen Needles Market Revenue Share, By Companies, 2024 |
11.2 North America Pen Needles Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Company Profiles |
13 Recommendations |
14 Disclaimer |